SCHEMBL4032316

SCHEMBL4032316

Cc1ccccc1-c1ccc2nc(-c3cccc(F)c3)cc(N(C)C)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 3/20 0.46
TSHR P16473 3/20 0.46
CYP2C19 P33261 3/20 0.46
CLK4 Q9HAZ1 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPK1 P28482 1/20 0.46
NT5E P21589 2/20 0.44
ACP1 P24666 2/20 0.43
ADORA2A P29274 1/20 0.43
NMT1 P30419 2/20 0.42
NMT2 O60551 1/20 0.42
AR P10275 1/20 0.39
CTSD P07339 1/20 0.39
BACE1 P56817 1/20 0.39
DHODH Q02127 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025761 0.85 NT5E (0.44) NT5EACP1ADORA2ANMT1DHODH
SCHEMBL4026356 0.85 NT5E (0.43) ALDH1A1NT5EACP1ADORA2ADHODH
SCHEMBL4031738 0.84 DHODH (0.45) CLK4NT5EACP1ADORA2ADHODH
SCHEMBL4028870 0.83 CYP1A2 (0.47) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL4825593 0.81 ACP1 (0.57) ALDH1A1ACP1ADORA2AHPGDABCG2
SCHEMBL4025078 0.80 RXFP1 (0.42) ACP1ADORA2AKDM4EHPGDNPSR1
SCHEMBL4823424 0.80 MAP4K4 (0.43) ALDH1A1NT5EACP1ADORA2ADHODH
SCHEMBL4022559 0.80 NT5E (0.49) NT5EACP1DHODHABCG2
SCHEMBL4027654 0.80 ACP1 (0.48) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL4025213 0.79 DHFR (0.44) CLK4NT5EACP1DHODHKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339690-B1 N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2009-01-21 EP disclosed